Skip to main content
. 2020 Sep 29;10(9):e036138. doi: 10.1136/bmjopen-2019-036138

Figure 2.

Figure 2

The network meta-analysis and the rankogram results for the International Society on Thrombosis and Haemostasis major or clinically relevant non-major bleeding. Estimates are presented in OR and 95% credible intervals. LD, low dose; P2Y12i, P2Y12 inhibitor; VKA, vitamin K antagonist.